6 days 7 hours ago
Globally, the prevalence of Type 2 Diabetes (T2D) among adolescents is increasing. While T2D is known to bring physical health challenges, less is known about adolescents’ psychosocial experiences of T2D. We aimed to identify and synthesize existing qualitative research about adolescents’ psychosocial experiences of T2D to inform healthcare recommendations.
Melissa Oxlad, Lorraine Smith, Tyla McNamara, Ashley Young, Ella Borrowdale, Alexia Pena
2 weeks ago
Rates of type 1(T1D) and type 2(T2D) diabetes in youth may be increasing globally; however, findings vary across populations. We aimed to determine changes in incidence and prevalence of T1D and T2D over a 25-year period (1994-2018) in youth under age 20 in Nova Scotia(NS).
Elizabeth A. Cummings, Teresa Pinto, Maya Rao, Pam Talbot
2 weeks 5 days ago
Delayed diagnosis of diabetes in children can lead to diabetic ketoacidosis, a life-threatening condition occurring in 10-80% of children at diabetes diagnosis. Ketoacidosis is preventable with prompt recognition of signs, urgent attendance to care, and rapid diagnosis and management. The objective of this study was to plan for the development of an intervention to recognize signs of diabetes in children and prevent ketoacidosis, that is evidence and theory-informed and has potential for widespread implementation and long-term impact across Canada.
Zeenat Ladak, Priscilla Medeiros, Geneviève Rouleau, Jennifer Shuldiner, Shazhan Amed, Elizabeth Cummings, Manpreet Doulla, Josephine Ho, Mark Inman, Sarah E. Lawrence, Patricia Li, Elizabeth Moreau, Meranda Nakhla, Julia Von Oettingen, Elizabeth Sellers…
4 weeks ago
To develop a machine learning model that accurately predicts the risk of acquiring COVID-19 in community-dwelling adults with type 1 and/or type 2 diabetes in Alberta, Canada.
Dean T. Eurich, Darren Lau, Weiting Li, Olivia Weaver, Tanya Joon, Ming Ye, Finlay A. McAlister, Padma Kaul, Salim Samanani
4 weeks 1 day ago
Lindsay S. Nagamatsu, Joyla A. Furlano, Samantha Marshall, Olivia Ghosh-Swaby, Gillian Rutherford, Jane Yardley
1 month 3 weeks ago
Social determinants of health (SDH) impact diabetes outcomes. In response to COVID-19, virtual care ensured healthcare access. However, socially disadvantaged groups have less technology access and skills, leading to potential disparities. We assessed the association between SDH and virtual visit success in children living with diabetes.
Laurence Bastien, Ellen B. Goldboom, Ewa Sucha, Richard J. Webster, Ivan Terekhov, Caroline Zuijdwijk
1 month 3 weeks ago
Published data still highlighted discordances between GMI (parameter estimating HbA1c from CGM report) and laboratory HbA1c, with reasons yet to be explored. This study aimed: to identify potential clinical factors contributing to these discordances.
Grażyna Deja, Aleksandra Brudzińska, Łukasz Wybrańczyk, Rafal Deja, Przemysława Jarosz-Chobot.
2 months ago
Diabetes and prediabetes are associated with premature death and are recognized as conditions of accelerated biologic aging. To date, the best measurement of biologic age is chronologic age. Measures of biologic age that can replace chronologic age as a predictor of death can better approximate risk in affected individuals.
Hertzel C. Gerstein, Guillaume Pare, Keyun Zhou, Serena Yang, Michael Chong, Gregory R. Steinberg, Shun Fu Lee
2 months 1 week ago
The rising incidence of type 2 diabetes (T2D) among Indigenous peoples, exacerbated by historical injustices and health inequities, underscores the need for culturally-sensitive health interventions that address both the physiological and psychological burdens of diabetes. This research protocol describes a community-driven initiative aimed at enhancing diabetes management among Indigenous youth and young adults in Canada, leveraging the lived experience and leadership of Indigenous young adults.
Sahar Fazeli, Jonathan Linton, Paul Linton, Lucy Trapper, Catherine Godin, Helene Porada, Deborah Da Costa, Kaberi Dasgupta, Isabelle Malhame, Claudia Mitchell, Elham Rahme, Julia Elisabeth Von Oettingen, Romina Pace
2 months 2 weeks ago
Trials using intensive lifestyle interventions have demonstrated remission of type 2 diabetes mellitus (T2DM), but data on real-world clinical approaches remain limited.
Christopher Gudas-Cantin, Valérie Dionne, Élise Latour, Karine Lamoureux, Lyne Chevrefils, Chantal Gariepy, Marie-Hélène Morissette C, Lina Mokdad, Juliette Morin, Sarah-Maude Martin, Mathieu Gayda, Florent Besnier, Sara Desmarais, Anil Nigam, Philippe L…
2 months 2 weeks ago
Kara Hawker, Justin Morein, Gurleen Gill, Irena Druce
2 months 2 weeks ago
Glucagon-like peptide 1 receptor agonists (GLP1RA), a relatively new class of drugs, are widely used in treating type 2 diabetes mellitus and obesity. Maintaining long-term glycemic control lowers the risk of development and progression of diabetic retinopathy. However, recent literature has raised concerns about transient worsening of the condition with GLP1RA use.
Nadia Nadeem, Raghad Mazin Al Issa, Asnin Shah, Rahaf Wardeh, Fauzia Rashid, Elamin Ibrahim Abdelgadir, Alaaeldin Bashier
2 months 2 weeks ago
Noor un nisa, Syeda Sana-e-Zehra Naqvi
2 months 4 weeks ago
Obesity and aging are associated with increased activity of the innate immune system. This chronic systemic inflammation contributes to the development of type 2 diabetes and long-term complications and is partly driven by the activation of the NLRP3 inflammasome. We conducted a comparative analysis of clinical parameters, non-esterified fatty acid (NEFA) profiles, immune cell subsets, and inflammatory responses of peripheral blood mononuclear cells obtained from both healthy individuals and those diagnosed with type 2 diabetes.
Joyce de Paula Souza, Justus S. Fischer, Karine Jeanneau, Cyril Allard, Eline Angevaare, Dominik Aschenbrenner, Ursula Bodendorf, Benjamin Demarco, John S. Gounarides, Saskia Killmer, Jiri Kovarik, Sabina Pfister, Hong Yin, Vithushan Ratnarasa, Marianne…
3 months ago
Patient-centered care is a hallmark of family medicine, and patient-centered care for diabetes has been associated with better outcomes. The Primary Care Diabetes Support Program (PCDSP) in London, Ontario, uses a patient-centered model of care and targets three groups of patients at high risk for diabetes complications: 1) medically complex, 2) socially complex, and 3) those without a primary care provider. We describe, from the patient’s perspectives, how the PCDSP operationalizes patient-centered care.
Gillian Young, Anika Garg, Dana Ryan, Leslie Meredith, Stewart Harris, Sonja M. Reichert, Lindsay Hedden, Maria Mathews
3 months 1 week ago
3 months 1 week ago
3 months 1 week ago
3 months 1 week ago
Muhammad Tabish, Hamna Khan, Muhammad Naveed
3 months 1 week ago
Krishna Jaipal, Sanjana Bebu Punshi, Mehak Kumari Bansari
Checked
1 hour 50 minutes ago
Canadian Journal of Diabetes RSS feed.
Subscribe to Canadian Journal of Diabetes feed
